» Articles » PMID: 11058597

IL-17E, a Novel Proinflammatory Ligand for the IL-17 Receptor Homolog IL-17Rh1

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2000 Nov 4
PMID 11058597
Citations 131
Authors
Affiliations
Soon will be listed here.
Abstract

We report identification of interleukin (IL)-17E, a novel member of the IL-17 family of cytokines. IL-17E is a ligand for the recently identified protein termed EVI27/IL-17BR, which we term IL-17 receptor homolog 1 (IL-17Rh1) in light of the multiple reported ligand-receptor relationships. Murine EVI27 was identified through its location at a common site of retroviral integration in BXH2 murine myeloid leukemias. IL-17Rh1 shows highest level expression in kidney with moderate expression in multiple other organs, whereas IL-17E mRNA was detected at very low levels in several peripheral tissues. IL-17E induces activation of NF-kappaB and stimulates production of the proinflammatory chemokine IL-8.

Citing Articles

Endometrial senescence is mediated by interleukin 17 receptor B signaling.

Kawamura K, Matsumura Y, Kawamura T, Araki H, Hamada N, Kuramoto K Cell Commun Signal. 2024; 22(1):363.

PMID: 39010112 PMC: 11247761. DOI: 10.1186/s12964-024-01740-5.


Interleukin-17 directly stimulates tumor infiltrating Tregs to prevent cancer development.

Theune W, Chen J, Theune E, Ye X, Menoret A, Vella A Front Immunol. 2024; 15:1408710.

PMID: 38947320 PMC: 11211274. DOI: 10.3389/fimmu.2024.1408710.


SCF Complex Targets Interleukin-17 Receptor A for Ubiquitin-Proteasome-Mediated Degradation.

Jin B, Moududee S, Ge D, Zhou P, Wang A, Liu Y Biomedicines. 2024; 12(4).

PMID: 38672111 PMC: 11047997. DOI: 10.3390/biomedicines12040755.


Targeting Interleukin-17 as a Novel Treatment Option for Fibrotic Diseases.

Sisto M, Lisi S J Clin Med. 2024; 13(1).

PMID: 38202170 PMC: 10780256. DOI: 10.3390/jcm13010164.


Evaluation of IL-6, IL-25 & IL-35 in the COVID 19 Patients and their Correlation to Demography Data in the Symptomatic Patients.

Mohammed H Al-Mquter L, Abdul Azeez Atiayh S Arch Razi Inst. 2023; 78(3):1049-1056.

PMID: 38028847 PMC: 10657937. DOI: 10.22092/ARI.2022.360087.2547.